Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Karyopharm Therapeutics Inc. | d529132dex321.htm |
| EX-31.2 - EX-31.2 - Karyopharm Therapeutics Inc. | d529132dex312.htm |
| EX-31.1 - EX-31.1 - Karyopharm Therapeutics Inc. | d529132dex311.htm |
| EX-21.1 - EX-21.1 - Karyopharm Therapeutics Inc. | d529132dex211.htm |
| EX-12.1 - EX-12.1 - Karyopharm Therapeutics Inc. | d529132dex121.htm |
| EX-10.30 - EX-10.30 - Karyopharm Therapeutics Inc. | d529132dex1030.htm |
| 10-K - 10-K - Karyopharm Therapeutics Inc. | d529132d10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| 1. | Registration Statement (Form S-8, File No. 333-194746) pertaining to the 2010 Stock Incentive Plan of Karyopharm Therapeutics Inc., 2013 Stock Incentive Plan of Karyopharm Therapeutics Inc., and 2013 Employee Stock Purchase Plan of Karyopharm Therapeutics Inc.; |
| 2. | Registration Statements (Form S-8, File Nos. 333-202742, 333-216732, and 333-223675) pertaining to the 2013 Stock Incentive Plan of Karyopharm Therapeutics Inc.; |
| 3. | Registration Statement (Form S-8, File No. 333-210221) pertaining to the 2013 Stock Incentive Plan of Karyopharm Therapeutics Inc. and 2013 Employee Stock Purchase Plan of Karyopharm Therapeutics Inc.; |
| 4. | Registration Statement (Form S-3, File No. 333-214489) and related Prospectus of Karyopharm Therapeutics Inc. for the registration of debt securities, common stock, preferred stock, and warrants; and |
| 5. | Registration Statement (Form S-3, File No. 333-222726) and related Prospectus of Karyopharm Therapeutics Inc. for the registration of debt securities, common stock, preferred stock, warrants, and units; |
of our report dated March 15, 2018, with respect to the consolidated financial statements of Karyopharm Therapeutics Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 15, 2018